Literature DB >> 30014297

Accumulation of microdamage at complete and incomplete fracture sites in a patient with bilateral atypical femoral fractures on glucocorticoid and bisphosphonate therapy.

Ken Iwata1, Tasuku Mashiba2, Satoshi Mori3, Tetsuji Yamamoto2.   

Abstract

Entities:  

Year:  2018        PMID： 30014297     DOI： 10.1007/s00774-018-0940-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  29 in total

1.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

Review 2.  Glucocorticoid-induced osteoporosis and osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-23       Impact factor: 4.741

3.  The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; Y Wada; T Nakatsue; S Iguchi; J Fujisawa; J J Kazama; T Kuroda; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2015-10-30       Impact factor: 4.507

4.  Crack growth resistance in cortical bone: concept of microcrack toughening.

Authors:  D Vashishth; J C Behiri; W Bonfield
Journal:  J Biomech       Date:  1997-08       Impact factor: 2.712

5.  Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Authors:  Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos
Journal:  Bone       Date:  2010-12-31       Impact factor: 4.398

6.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

7.  Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.

Authors:  Satoshi Komatsubara; Satoshi Mori; Tasuku Mashiba; Masako Ito; Jiliang Li; Yoshio Kaji; Tomoyuki Akiyama; Kensaku Miyamoto; Yongping Cao; Jun Kawanishi; Hiromichi Norimatsu
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

8.  Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution.

Authors:  N L Fazzalari; J S Kuliwaba; M R Forwood
Journal:  Bone       Date:  2002-12       Impact factor: 4.398

9.  Incidence of atypical nontraumatic diaphyseal fractures of the femur.

Authors:  Richard M Dell; Annette L Adams; Denise F Greene; Tadashi T Funahashi; Stuart L Silverman; Eric O Eisemon; Hui Zhou; Raoul J Burchette; Susan M Ott
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

10.  Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.

Authors:  Satoshi Komatsubara; Satoshi Mori; Tasuku Mashiba; Jilliang Li; Kiichi Nonaka; Yoshio Kaji; Tomoyuki Akiyama; Kensaku Miyamoto; Yongping Cao; Jun Kawanishi; Hiromichi Norimatsu
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741
View more
  1 in total

1.  Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance.

Authors:  Cheng-Hui Ke; Hong-Yun Li; Dan Yang; Hao Ying; Jun Xu; Jian Wang; Hong-Wen Zhu; Lin Wang
Journal:  Orthop Surg       Date:  2021-10-21       Impact factor: 2.071
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.